Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Chest
|
June 1, 1995
Percutaneous needle biopsy of localized pulmonary, mediastinal, and pleural diseased tissue with an automatic disposable guillotine soft-tissue needle. Preliminary results
M M Noppen, J De Mey, M Meysman, et al.
The European Respiratory Journal
|
July 1, 1990
Oral treatment with itraconazole of aspergilloma in cavitary lung cancer
N Impens, J De Greve, K De Beule, et al.
The American Journal of Gastroenterology
|
August 1, 1993
Systemic amyloidosis-induced diarrhea in sex-linked agammaglobulinemia
M Meysman, S Debeuckelaer, H Reynaert, et al.
The European Respiratory Journal
|
May 27, 2003
Recurrent tracheal mass
M Meysman, M Noppen, J De Mey, et al.
Respiratory Medicine
|
May 20, 2006
Stenting allows weaning and extubation in ventilator- or tracheostomy dependency secondary to benign airway disease
M Noppen, G Stratakos, K Amjadi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2014
Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients
C Collen, N Christian, D Schallier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 6, 2007
A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC)
D Schallier, B Neyns, C Fontaine, et al.
The European Respiratory Journal
|
July 1, 1995
Non-small-cell lung cancer with multiple paraneoplastic syndromes
I Monsieur, M Meysman, M Noppen, et al.
Acta Clinica Belgica
|
April 25, 2007
Primary tracheobronchial amyloidosis: a series of 3 cases
S Hanon, T De Keukeleire, B Dieriks, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 9, 2008
Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)
L Decoster, D Schallier, H Everaert, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Chest
|
June 1, 1995
Percutaneous needle biopsy of localized pulmonary, mediastinal, and pleural diseased tissue with an automatic disposable guillotine soft-tissue needle. Preliminary results
M M Noppen, J De Mey, M Meysman, et al.
The European Respiratory Journal
|
July 1, 1990
Oral treatment with itraconazole of aspergilloma in cavitary lung cancer
N Impens, J De Greve, K De Beule, et al.
The American Journal of Gastroenterology
|
August 1, 1993
Systemic amyloidosis-induced diarrhea in sex-linked agammaglobulinemia
M Meysman, S Debeuckelaer, H Reynaert, et al.
The European Respiratory Journal
|
May 27, 2003
Recurrent tracheal mass
M Meysman, M Noppen, J De Mey, et al.
Respiratory Medicine
|
May 20, 2006
Stenting allows weaning and extubation in ventilator- or tracheostomy dependency secondary to benign airway disease
M Noppen, G Stratakos, K Amjadi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2014
Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients
C Collen, N Christian, D Schallier, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 6, 2007
A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC)
D Schallier, B Neyns, C Fontaine, et al.
The European Respiratory Journal
|
July 1, 1995
Non-small-cell lung cancer with multiple paraneoplastic syndromes
I Monsieur, M Meysman, M Noppen, et al.
Acta Clinica Belgica
|
April 25, 2007
Primary tracheobronchial amyloidosis: a series of 3 cases
S Hanon, T De Keukeleire, B Dieriks, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 9, 2008
Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)
L Decoster, D Schallier, H Everaert, et al.
Page
of 6